- Home
- NTRS vs PODD Comparison
NTRS vs PODD Comparison
Compare NTRS & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NTRS | PODD |
|---|---|---|
| Founded | 1889 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3B | 22.1B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | NTRS | PODD |
|---|---|---|
| Price | $133.11 | $304.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 19 |
| Target Price | $127.77 | ★ $359.00 |
| AVG Volume (30 Days) | ★ 930.2K | 765.6K |
| Earning Date | 01-22-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.40% | N/A |
| EPS Growth | ★ 7.22 | N/A |
| EPS | ★ 8.58 | 3.45 |
| Revenue | ★ $7,932,900,000.00 | $2,521,800,000.00 |
| Revenue This Year | N/A | $32.55 |
| Revenue Next Year | $4.02 | $20.39 |
| P/E Ratio | ★ $15.53 | $88.24 |
| Revenue Growth | 0.96 | ★ 27.11 |
| 52 Week Low | $81.62 | $230.05 |
| 52 Week High | $135.48 | $354.88 |
Technical Indicators
Market Signals| Indicator | NTRS | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 61.60 | 40.94 |
| Support Level | $129.98 | $303.20 |
| Resistance Level | $133.80 | $317.34 |
| Average True Range (ATR) | 2.72 | 13.12 |
| MACD | 0.60 | -2.82 |
| Stochastic Oscillator | 94.34 | 3.14 |
Price Performance
Historical ComparisonAbout NTRS Northern Trust Corporation
Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of December 2024, Northern Trust had assets under custody or administration of $16.8 trillion and assets under management of $1.6 trillion.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.